308 related articles for article (PubMed ID: 11503955)
1. The role of apoptosis in the pathogenesis of the myelodysplastic syndromes.
Parker JE; Mufti GJ
Int J Hematol; 2001 Jun; 73(4):416-428. PubMed ID: 11503955
[TBL] [Abstract][Full Text] [Related]
2. Excessive apoptosis in low risk myelodysplastic syndromes (MDS).
Parker JE; Mufti GJ
Leuk Lymphoma; 2000 Dec; 40(1-2):1-24. PubMed ID: 11426609
[TBL] [Abstract][Full Text] [Related]
3. The myelodysplastic syndromes: a matter of life or death.
Parker JE; Mufti GJ
Acta Haematol; 2004; 111(1-2):78-99. PubMed ID: 14646347
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia.
Irvine AE; Magill MK; Somerville LE; McMullin MF
Exp Hematol; 1998 May; 26(5):435-9. PubMed ID: 9590661
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndromes: the complexity of stem-cell diseases.
Corey SJ; Minden MD; Barber DL; Kantarjian H; Wang JC; Schimmer AD
Nat Rev Cancer; 2007 Feb; 7(2):118-29. PubMed ID: 17251918
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated human myeloid nuclear differentiation antigen expression in myelodysplastic syndromes: evidence for a role in apoptosis.
Briggs RC; Shults KE; Flye LA; McClintock-Treep SA; Jagasia MH; Goodman SA; Boulos FI; Jacobberger JW; Stelzer GT; Head DR
Cancer Res; 2006 May; 66(9):4645-51. PubMed ID: 16651415
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis, etiology and epidemiology of myelodysplastic syndromes.
Aul C; Bowen DT; Yoshida Y
Haematologica; 1998 Jan; 83(1):71-86. PubMed ID: 9542325
[TBL] [Abstract][Full Text] [Related]
8. Biology of the bone marrow microenvironment and myelodysplastic syndromes.
Rankin EB; Narla A; Park JK; Lin S; Sakamoto KM
Mol Genet Metab; 2015; 116(1-2):24-8. PubMed ID: 26210353
[TBL] [Abstract][Full Text] [Related]
9. Unveiling the paradoxical nature of myelodysplastic syndromes (MDS): why hypercellular marrow strongly favors accelerated apoptosis.
Das M; Chaudhuri S; Law S
Biochem Cell Biol; 2013 Oct; 91(5):303-8. PubMed ID: 24032679
[TBL] [Abstract][Full Text] [Related]
10. Stem cell origin of myelodysplastic syndromes.
Elias HK; Schinke C; Bhattacharyya S; Will B; Verma A; Steidl U
Oncogene; 2014 Oct; 33(44):5139-50. PubMed ID: 24336326
[TBL] [Abstract][Full Text] [Related]
11. Nuclear PI-PLC β1 and Myelodysplastic syndromes: from bench to clinics.
Mongiorgi S; Follo MY; Clissa C; Giardino R; Fini M; Manzoli L; Ramazzotti G; Fiume R; Finelli C; Cocco L
Curr Top Microbiol Immunol; 2012; 362():235-45. PubMed ID: 23086421
[TBL] [Abstract][Full Text] [Related]
12. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis in the myelodysplastic syndromes.
Westwood NB; Mufti GJ
Curr Hematol Rep; 2003 May; 2(3):186-92. PubMed ID: 12901339
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis and prognostic factors in myelodysplastic syndromes.
Shimazaki K; Ohshima K; Suzumiya J; Kawasaki C; Kikuchi M
Leuk Lymphoma; 2002 Feb; 43(2):257-60. PubMed ID: 11999555
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes.
Raza A; Gezer S; Mundle S; Gao XZ; Alvi S; Borok R; Rifkin S; Iftikhar A; Shetty V; Parcharidou A
Blood; 1995 Jul; 86(1):268-76. PubMed ID: 7795232
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
Pleyer L; Valent P; Greil R
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
[TBL] [Abstract][Full Text] [Related]
17. New Insights into the Pathogenesis of MDS and the rational therapeutic opportunities.
Abou Zahr A; Bernabe Ramirez C; Wozney J; Prebet T; Zeidan AM
Expert Rev Hematol; 2016; 9(4):377-88. PubMed ID: 26734762
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis.
Raza A; Mundle S; Iftikhar A; Gregory S; Marcus B; Khan Z; Alvi S; Shetty V; Dameron S; Wright V
Am J Hematol; 1995 Mar; 48(3):143-54. PubMed ID: 7864021
[TBL] [Abstract][Full Text] [Related]
19. Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia.
Watson AS; Mortensen M; Simon AK
Cell Cycle; 2011 Jun; 10(11):1719-25. PubMed ID: 21512311
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of caspases activity of hematopoietic progenitor cells and its significance in myelodysplastic syndromes].
Chen JL; Xu M; Song XZ; Li Q; Li RS
Zhonghua Xue Ye Xue Za Zhi; 2003 Nov; 24(11):565-7. PubMed ID: 14720439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
